Form 4: Envoy Medical Director Glen A. Taylor Boosts Stake with New Warrant Issuance

Glen A. Taylor, a Director and 10% owner of Envoy Medical, Inc., has increased his beneficial ownership through direct and indirect holdings, including the acquisition of a new warrant for 750,000 shares of Class A Common Stock.

Summary

• Glen A. Taylor, a Director and 10% owner of Envoy Medical, Inc. (COCH), beneficially owns a total of 10,290,049 shares of Class A Common Stock.
• This total includes 2,953,607 shares held directly, 2,526,058 shares held indirectly by Taylor Sports Group (an entity he owns and chairs), and 4,810,384 shares held indirectly by GAT Funding, LLC (an entity he controls).
• GAT Funding, LLC also beneficially owns derivative securities, including Series A Preferred Stock convertible into 869,565 shares of Class A Common Stock at an exercise price of $11.5, which are fully exercisable with no expiration date.
• Additionally, GAT Funding, LLC holds multiple warrants to purchase Class A Common Stock, totaling 3,500,000 shares, with exercise prices ranging from $1.24 to $3.04 and expiration dates between February 27, 2026, and March 11, 2028.
• A new warrant for 750,000 shares of Class A Common Stock was issued to GAT Funding, LLC on June 26, 2025, with an exercise price of $1.48 and an expiration date of June 26, 2027.
• This new warrant issuance is in connection with a promissory note issuance effective March 6, 2025, and the closing of the final funding on June 26, 2025, as further detailed in the Issuer's 8-K filed on July 2, 2025.

Sentiment

Score: 7

Explanation: The filing indicates increased beneficial ownership by a key insider and is tied to a recent funding event, which generally signals positive commitment and financial activity for the company.

Positives

• Glen A. Taylor, a Director and 10% owner, has increased his beneficial ownership in Envoy Medical, Inc., signaling continued commitment and confidence in the company.
• The acquisition of a new warrant is tied to a recent funding event, indicating successful capital infusion for the company.

Future Outlook

The issuance of the new warrant is directly linked to a promissory note and the closing of final funding, suggesting ongoing financial activities and strategic developments for Envoy Medical, Inc. The details of these funding activities are expected to be elaborated in the Issuer's 8-K filing.

Industry Context

This filing is a standard disclosure of insider ownership changes, which provides transparency into the holdings of key personnel. It does not contain information to assess broader industry trends or competitive positioning.

Related Party Transactions

• The issuance of a new warrant to GAT Funding, LLC, an entity controlled by Glen A. Taylor (a Director and 10% owner), constitutes a related party transaction.

Stakeholder Impact

• Shareholders: Increased insider ownership may be viewed positively as a sign of confidence, but the potential exercise of warrants could lead to future dilution.
• Creditors: The promissory note issuance and funding closing indicate ongoing financial activity that could impact the company's capital structure and ability to meet obligations.

Next Steps

• Refer to the Issuer's 8-K filing on July 2, 2025, for more detailed information regarding the promissory note issuance and the final funding closing.

Key Dates

Keywords

Envoy Medical, COCH, Glen A. Taylor, Insider Ownership, Beneficial Ownership, Warrants, Preferred Stock, SEC Form 4, Capital Raise, Director Holdings